CD4 and undifferentiated pancreatic carcinoma: Among vaccinated patients, all except one (30/31) who developed anti-UCP IgG Abs also exhibited a concurrent UCP-specific CD4+ Th1 response, compared to only 4 patients in the group without a detectable Ab response (4/19) (Figure 5E).